bibliographic entry 4978067 [be/4978067]
https://w3id.org/oc/corpus/be/4978067

is a

• bibliographic reference

content

• Kakkis ED, O'Donovan M, Cox G, Hayes M, Goodsaid F, Tandon PK et al. Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints. Orphanet J Rare Dis 2015; 10: 16. PMID: 25757705

references

• https://w3id.org/oc/corpus/br/1259560